Stroke, Vol 23, 1287-1291, Copyright © 1992 by American Heart Association
MJ Yu, JR McCowan, EB Smalstig, DR Bennett, ME Roush and JA Clemens
BACKGROUND AND PURPOSE: We previously reported that 2-(10H-phenothiazin-
2-yloxy)-N,N-dimethylethanamine hydrochloride is a potent inhibitor of
iron-dependent lipid peroxidation in vitro and can protect primary cultures
of rat hippocampal neurons from hydrogen peroxide-induced toxicity. Because
oxidants may play an important role in mediating postischemic tissue
injury, we evaluated this agent in two rat models of transient cerebral
ischemia. METHODS: In a model of global forebrain ischemia, 23 male Wistar
rats were subjected to 10 minutes of four- vessel occlusion followed by 72
hours of reperfusion. The rats received three intraperitoneal injections of
either vehicle (2% aqueous acacia) or test agent (40 mg/kg). In a model of
focal stroke, 19 spontaneously hypertensive rats were subjected to 2 hours
of tandem middle cerebral and ipsilateral common carotid artery occlusion
followed by 24 hours of reperfusion. The rats received three
intraperitoneal injections of either vehicle (2% aqueous acacia) or test
agent (40 mg/kg). RESULTS: In the global model, the phenothiazine
significantly protected the CA1 layer of the hippocampus, with a reduction
in mean damage score from 2.1 +/- 0.3 for control rats to 1.0 +/- 0.4 for
treated rats (p less than 0.05). In the transient focal stroke model, the
compound reduced cortical infarct volume from 130.1 +/- 10.3 mm3 for
control rats to 95.2 +/- 24.5 mm3 for treated rats (p less than 0.02).
CONCLUSIONS: Although the primary mechanism responsible for the protective
effect is unclear at the present time, our study is consistent with the
hypothesis that oxidant-mediated lipid peroxidation may be involved in the
pathophysiology of postischemic brain injury.
ARTICLES
A phenothiazine derivative reduces rat brain damage after global or focal ischemia
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind. 46285.
This article has been cited by other articles:
![]() |
S. Kuroda, A. Nakai, T. Kristian, and B. K. Siesjo The Calmodulin Antagonist Trifluoperazine in Transient Focal Brain Ischemia in Rats : Anti-ischemic Effect and Therapeutic Window Stroke, December 1, 1997; 28(12): 2539 - 2544. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |